Skip to content

September 22, 2022

Saffr’Activ on ADHD disease

The prestigious journal  has published the first study of Saffr’Activ on ADHD disease: “Effectivity of Saffron Extract (Saffr’Activ) on Treatment for Children and Adolescents with Attention Deficit/Hyperactivity Disorder (ADHD): A Clinical Effectivity Study Amazing evidences, in comparison with drug methylphenidate.” This study compares the efficacy of saffron and the usual treatment with methylphenidate, using objective and pen-and-paper tests. We performed a non-randomized clinical trial with two groups, methylphenidate (n = 27) and saffron (n = 36), in children and adolescents aged 7 to 17. Results show that the efficacy of saffron is comparable to that of methylphenidate. Saffron is more effective for treating hyperactivity symptoms, while methylphenidate is more effective for inattention symptoms.

Find the whole article here: Open Access

Share:

You might be also interested in

Saffr’Activ®: a unique standardization based on crocins
March 15, 2018

Crocins & safranal: the two major active components of saffron flower Saffr’Activ® is rich in many active compounds such as crocins, safranal, picrocrocins, flavonoids and […]

October 22, 2022

This year took place VITAFOODS Asia 2022 trade fair, the most important event of Nutraceuticals on the Asian market, which took place in Bangkok, Thailand […]

April 22, 2024

Using saffron extract to complete a sport diet could be very helpful because Crocus sativus has compelling properties for sportsmen and women, as shown in […]

September 25, 2019

Comercial Química Massó is exhibiting for the first time at the prestigious VITAFOODS Asia 2019 trade fair, which took place on 25 and 26 September […]